Supplementary figures S1-S5 from Tipifarnib potentiates the antitumor effects of PI3Kα inhibition in PIK3CA- and HRAS-dysregulated HNSCC via convergent inhibition of mTOR activity
Authors:
- Alison E. SmithASAlison E. Smith
- Stacia ChanSCStacia Chan
- Zhiyong WangZWZhiyong Wang
- Asako McCloskeyAMAsako McCloskey
- Quinn ReillyQRQuinn Reilly
- Jayden Z. WangJWJayden Z. Wang
- Hetika Vora. PatelHPHetika Vora. Patel
- Keiichi KoshizukaKKKeiichi Koshizuka
- Harris S. SoiferHSHarris S. Soifer
- Linda KesslerLKLinda Kessler
- Ashley DayoubADAshley Dayoub
- Victoria VillaflorVVVictoria Villaflor
Open Access
- 16 September 2024
- other
- Published by American Association for Cancer Research (AACR)